Research / MLAB / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-25-024715 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
118.09% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.69% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
3.18% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
2.36% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
47.20% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
62.04% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
5.15% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
8.37% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
6.52% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 12 states History building
Sep 30, 2023 0/7 normalized Level 3 Dec 31, 2023 0/7 normalized Level 3 Mar 31, 2024 0/7 normalized Level 3 Jun 30, 2024 0/8 normalized Level 3 Sep 30, 2024 0/9 normalized Level 3 Dec 31, 2024 0/9 normalized Level 3 Mar 31, 2025 0/9 normalized Level 3 Jun 30, 2025 0/9 normalized Level 3 Sep 30, 2025 7/9 normalized Level 3 Dec 31, 2025 7/9 normalized Level 3 Mar 31, 2026 7/9 normalized Level 3 Jun 30, 2026 8/9 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 29.57%
Current 118.09%
Delta 88.52% Capex Intensity Decreased
Previous 1.76%
Current 1.69%
Delta -0.07% Cash Generation Decreased
Previous 19.42%
Current 3.18%
Delta -16.25% Growth Decreased
Previous 11.47%
Current 2.36%
Delta -9.11% Inventory Pressure Increased
Previous 10.53%
Current 47.20%
Delta 36.68% Margin Decreased
Previous 62.61%
Current 62.04%
Delta -0.57% Profitability Decreased
Previous 6.78%
Current 5.15%
Delta -1.63% R And D Intensity Increased
Previous 8.10%
Current 8.37%
Delta 0.27% Sbc Intensity Increased
Previous 5.45%
Current 6.52%
Delta 1.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.